Symposia 3 - The WHO System for Reporting Pancreaticobiliary Cytopathology: The Rationale, Structure, Categories and Applica
Tracking # 20-1038334
$99999.00
There are no ratings for this course
Learn moreCourse overview
The World Health Organization (WHO), the International Academy of Cytology (IAC) and the and the International Agency for Research on Cancer (IARC) have joined forces to publish a series of cytopathology reporting systems, which will present an international approach to reporting cytopathology of various body sites and mirror the WHO Classification of Tumurs series (with links between the two series). These reporting systems will provide an evidence-based terminology system with associated risk of malignancy and management recommendation per diagnostic category aimed to facilitate diagnosis and patient management. This symposium introduces the Reporting System for Pancreaticobiliary Cytology, which is a revision of the Papanicolaou Society of Cytopathology System of Reporting Pancreaticobiliary Cytology. The WHO System will be described and modifications from the PSC System will be explained. The subsequent case-based seminar will illustrate the application of the WHO System in practice.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.
The following individuals have reported financial relationships:
Michael Berry, SCT(ASCP)MBCM: Stockholder-Hologic
Lukas Bubendorf, MD, MIAC: Advisory Board - Astra Zeneca, Bayer, Eli Lilly, BMS, Takeda; Research Support - Sanofi, Systems Oncology, Thermo Fisher; Speaker's Fee - Thermo Fisher; Consultant – Systems Oncology, Janssen
Oscar Lin, MD, PhD: Consultant – Hologic and Jansen
Liron Pantanowitz, MD: Consultant – Hamamatsu, Advisory Board for Ibex
Martha B. Pitman, MD, FIAC: Consultant – Adenocyte, LLC
Donna K. Russell, MEd, CT(ASCP), HT(ASCP): Advisory Board – Hologic Scientific
Christopher J. VandenBussche, MD, PhD: Ad hoc advisory board panel and Consultant – Roche
Paul VanderLaan, MD, PhD: Consultant – Gala Therapeutics